Cholangiographic and clinical variables among different categories of extrahepatic bile duct obstruction
| Variable | Cast (n = 10) | Stones (n = 11) | Haemobilia (n = 11) | |
|---|---|---|---|---|
| PTA related (n = 8) | HCC related (n = 3) | |||
| PTA, percutaneous tumour ablation; HCC, hepatocellular carcinoma; T bilirubin, total bilirubin; PEIT, percutaneous ethanol injection therapy; PMCT, percutaneous microwave coagulation therapy; RFA, radiofrequency ablation; TAE, transarterial embolisation; PVTT, portal vein tumour thrombus; γ-GTP, gamma-glutamyl transpeptidase. | ||||
| Period after initial PTA (months) | 7–72 (32) | 0–88 (27) | 0–42 (7.8) | 30–99 (55) |
| Period after latest PTA (months) | 0–12 (3) | 0–17 (6.5) | 0 | 2–10 (5.3) |
| T bilirubin (mg/dl) | 0.5–4.1 (2.0) | 1.0–15.9 (4.3) | 1.7–26.3 (7.9) | 8–29 (19.3) |
| Alkaline phosphatase (IU/l) | 146–1485 (553) | 248–1065 (417) | 229–787 (470) | 448–965 (625) |
| γ-GTP (IU/l) | 51–952 (268) | 34–253 (110) | 53–649 (267) | 111–494 (309) |
| Abdominal pain | 4/10 (40%) | 6/11 (55%) | 4/8 (50%) | 3/3 (100%) |
| Pancreatitis | 0/10 (0%) | 3/11 (27%) | 0/8 (0%) | 0/3 (0%) |
| Liver abscess | 5/10 (50%) | 2/11 (18%) | 0/8 (0%) | 0/3 (0%) |
| Gallstone | 2/10 (20%) | 10/10 (100%) | 3/8 (40%) | 0/2 (0%) |
| “Haemobilia sign” | 1/10 (10%) | 0/11 (0%) | 8/8 (100%) | 1/2 (50%) |
| Biliary strictures | 9/10 (90%) | 2/11 (18%) | 1/8 (13%) | 1/3 (33%) |
| Type of PTA (PEIT/PMCT/RFA) | 10/2/1 | 9/1/2 | 8/0/0 | 3/0/0 |
| History of TAE | 8/10 (80%) | 6/11 (55%) | 2/8 (25%) | 1/3 (33%) |
| Size of HCC (cm) | 0–8.5 (2.9) | 0–7.5 (3.2) | 1.5–6 (3.4) | 2 |
| PVTT | 1/10 (10%) | 1/11 (9%) | 2/8 (25%) | 1/3 (33%) |
| Additional therapy | None | None | TAE 1 | Surgery for HCC 2, PTA 1 |
| Immediate prognosis | ||||
| Recovered | 10/10 (100%) | 11/11 (100%) | 6/8 (75%) | 3/3 (100%) |
| Died | 2/8 (25%) | |||